Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture

• Glen A. Coburn ,

  * E-mail: gcoburn@progenics.com

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Danielle N. Fisch,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Sameer M. Moorji,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Jean-Marc de Muys,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Jose D. Murga,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Dorothy Paul,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Kathleen P. Provoncha,

  Current address: ContraFect Corporation, Yonkers, New York, United States of America

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Yakov Rotshteyn,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Amy Q. Han,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Dapeng Qian,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• Paul J. Maddon,

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯
• William C. Olson

  Affiliation Research and Development, Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  ⨯